Klok 2016 VTE-BLEED for major bleeding on stable anticoagulation after VTE. Six items: active cancer 2; male with uncontrolled hypertension (SBP ≥140) 1; anemia 1.5; history of bleeding 1.5; age ≥60 1.5; renal dysfunction (eGFR/CrCl <60) 1.5; max 9. Low <2, high ≥2. Caller-assigned flags; magent does not assay hemoglobin or eGFR. Not a medical device, not HAS-BLED, and not a treatment-duration order.

Payment Options